Home » Topics » Regulatory » Patents

Patents
RSS

Bayer Schering Pharma describes ATR kinase inhibitors

Feb. 19, 2016

Kasuma Partners patents PCSK9 inhibitors

Feb. 19, 2016

Northeastern University has introduced FAAH and MAGL inhibitors

Feb. 18, 2016

HEC Pharm discloses cyclin-dependent kinase inhibitors

Feb. 18, 2016

Teijin Pharma reports xanthine oxidase inhibitors

Feb. 18, 2016

Merck & Co. reports calcitonin gene-related peptide receptor antagonists

Feb. 18, 2016

Nanjing Sanhome reports compounds for the treatment of HCV infections

Feb. 17, 2016

Novartis patents antibacterial quinolone derivatives

Feb. 17, 2016

Siena Biotech and Roche report BACE1 inhibitors

Feb. 16, 2016

Gilead Sciences discloses antiviral agents

Feb. 16, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...